Variables | Category | N = 295 | % from N | VTF = 49 | % |
---|---|---|---|---|---|
Current ART regimen | 1c | 53 | 18.0 | 16 | 32.65 |
1d | 82 | 27.8 | 12 | 24.49 | |
1e | 135 | 45.8 | 15 | 30.61 | |
1f | 16 | 5.4 | 2 | 4.08 | |
4c | 9 | 3.1 | 4 | 8.16 | |
Baseline ART regimen | 1a | 26 | 8.8 | 4 | 8.16 |
1b | 40 | 13.6 | 8 | 16.33 | |
1c | 37 | 12.5 | 8 | 16.33 | |
1d | 68 | 23.1 | 12 | 24.49 | |
1e | 110 | 37.3 | 11 | 22.45 | |
4c | 14 | 4.7 | 6 | 12.24 | |
Drug substitution | None | 208 | 70.5 | 31 | 63.27 |
Once | 87 | 29.5 | 18 | 36.73 | |
Current CD4 result | ≤ 100 | 23 | 7.8 | 14 | 28.57 |
101–250 | 86 | 29.2 | 20 | 40.82 | |
251–500 | 88 | 29.8 | 11 | 22.45 | |
501 + | 98 | 33.2 | 4 | 8.16 | |
Current clinical stage | I | 265 | 89.8 | 34 | 69.39 |
II | 24 | 8.13 | 12 | 24.49 | |
III | 6 | 2.03 | 3 | 6.12 | |
Baseline clinical stage | I | 59 | 20.0 | 7 | 14.29 |
II | 124 | 42.0 | 21 | 42.86 | |
III | 98 | 33.2 | 18 | 36.73 | |
IV | 14 | 4.7 | 3 | 6.12 | |
The dose of ART per day | Once | 131 | 44.4 | 15 | 30.61 |
Twice | 164 | 55.6 | 34 | 69.39 | |
Drug interruption | No | 261 | 88.5 | 37 | 75.51 |
Yes | 34 | 11.5 | 12 | 24.49 | |
Drug adherence | ≥ 95% | 189 | 64.1 | 11 | 22.45 |
< 95% | 106 | 35.9 | 38 | 77.55 | |
Prophylaxis use | No | 285 | 96.6 | 44 | 89.80 |
Yes | 10 | 3.4 | 5 | 10.80 | |
Baseline function status | Bedridden | 28 | 9.5 | 7 | 14.29 |
Ambulatory | 184 | 62.4 | 28 | 57.14 | |
Working | 83 | 28.1 | 14 | 28.57 | |
TB history | No | 242 | 82 | 36 | 73.47 |
Yes | 53 | 18 | 13 | 26.53 | |
Disclosure | No | 71 | 24.1 | 10 | 20.41 |
Yes | 224 | 75.9 | 39 | 79.59 | |
Duration/month on ART | 6–24 | 29 | 9.8 | 1 | 2.04 |
25–48 | 39 | 13.2 | 4 | 8.16 | |
49–72 | 57 | 19.3 | 7 | 14.29 | |
73 + | 170 | 57.6 | 37 | 75.51 | |
Baseline CD4 result | ≤ 100 | 150 | 50.8 | 26 | 53.06 |
101–250 | 88 | 29.8 | 15 | 30.61 | |
251–500 | 28 | 9.5 | 3 | 6.12 | |
501 + | 29 | 9.8 | 5 | 10.20 |